Treatment of high-risk T-NHL with autologous or allogeneic stem cell transplantation

被引：0
|
作者：
Busemann, C. [1 ]
Klein, S. [1 ]
Schmidt, C. A. [1 ]
Evert, M. [1 ]
Doelken, G. [1 ]
Krueger, W. H. [1 ]
机构：
[1] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S542 / S543
页数：2
相关论文
共 50 条
  • [41] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF HIGH-RISK PEDIATRIC RHABDOMYOSACROMA PATIENTS
    Shiriaev, S. N.
    Makarova, I. V.
    Kazantsev, I. V.
    Gevorgyan, A. G.
    Kozlov, A. V.
    Youkhta, T. V.
    Klimov, A. S.
    Shvetsov, A. N.
    Morozova, E. V.
    Zubarovskaya, L. S.
    Afanasiev, B. V.
    Safonova, S. A.
    Punanov, Y. A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 237 - 237
  • [42] The Efficacy of High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Osteosarcoma
    Sakiyama, Hideki
    Hamada, Satoru
    Yagi, Takeshi
    Miyamoto, Jiro
    Oshiro, Tokiko
    Uehara, Taichi
    Kiyuna, Shinobu
    Tome, Yasunori
    Maehara, Hiroki
    Matsuda, Takehiro
    Higa, Takeshi
    Hyakuna, Nobuyuki
    Nakanishi, Koichi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S60 - S60
  • [43] Outcome of Allogeneic and Autologous Hematopoietic Cell Transplantation for High-Risk Peripheral T Cell Lymphomas: A Retrospective Analysis From a Chinese Center
    Huang, Haiwen
    Jiang, Yibin
    Wang, Qiangli
    Guo, Lingchuan
    Jin, Zhengming
    Fu, Zhengzheng
    Han, Yue
    Sun, Aining
    Liu, Wei
    Ruan, Jia
    Wu, Depei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (08) : 1393 - 1397
  • [44] Allogeneic stem cell transplantation from HLA identical donor in high-risk sarcoma
    Prete, A.
    Rondelli, R.
    Locatelli, F.
    Caselli, D.
    Lanino, E.
    Messina, C.
    Masetti, R.
    Pedrazzoli, P.
    Ferrari, S.
    Pession, A.
    Fagioli, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S174 - S175
  • [45] Allogeneic Halpo-Identical Hematopoietic Stem Cell Transplantation for High-Risk Leukemia
    Wang, Jing Bo
    Fei, Xin Hong
    Yin, Yu Ming
    Cheng, Hao Yu
    Zhang, Wei Jie
    Cu, Jiang Ying
    Xue, Song
    Li, Qian
    Yang, Fan
    Zhang, Shu Qin
    He, Jun Bao
    Liu, Meng Qi
    Zhao, Jie
    Liu, Dai-Hong
    BLOOD, 2015, 126 (23)
  • [46] Analysis of the efficacy of autologous peripheral blood stem cell transplantation in high-risk neuroblastoma
    Yan, Jin
    Jie, Li
    Jiaxing, Yang
    Yanna, Cao
    Zhanglin, Li
    Zhongyuan, Li
    Daowei, Wang
    Guangzong, Zhao
    Benfu, Zhong
    Jie, Yan
    Qiang, Zhao
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (11): : 1715 - 1723
  • [47] Autologous stem cell transplantation for high-risk lymphoma -: a single-centre experience
    Theorin, N
    Radlund, A
    Seger-Mollén, A
    Juliusson, G
    Malm, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S351 - S351
  • [48] Immunotherapy for high-risk neuroblastoma: allogeneic stem cell transplantation and recipient leucocyte infusion
    de Casterle, I. Dierckx
    Rutgeerts, O.
    Fevery, S.
    Lenaerts, C.
    Waer, M.
    Billiau, A.
    Sprangers, B.
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [49] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT) IN HIGH-RISK MYELOMA (MM)
    MARIT, G
    PICO, JL
    BOIRON, JM
    FOURES, C
    BERNARD, P
    BROUSTET, A
    REIFFERS, J
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 558 - 558
  • [50] Using genomics to identify high-risk myeloma after autologous stem cell transplantation
    Shaughnessy, JD
    Barlogie, B
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 77 - 80
12345